Edition:
United Kingdom

Carmat SA (ALCAR.PA)

ALCAR.PA on Paris Stock Exchange

26.45EUR
24 Sep 2018
Change (% chg)

-- (--)
Prev Close
€26.45
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
9,644
52-wk High
€29.50
52-wk Low
€19.50

Latest Key Developments (Source: Significant Developments)

Carmat Completes Patient Enrollment In First Part Of PIVOTAL Study
Wednesday, 11 Jul 2018 

July 11 (Reuters) - CARMAT SA ::COMPLETES PATIENT ENROLLMENT IN THE FIRST PART OF THE PIVOTAL STUDY IN LINE WITH THE OBJECTIVE OF OBTAINING CE MARKING IN 2019.STUDY PACE IN LINE WITH OBJECTIVE OF FINALIZING PATIENT ENROLLMENT BEFORE END-2018.CONFIRMS OBJECTIVE TO REACH 20 IMPLANTED PATIENTS BY YEAR-END.IMPLANTATION OF 50% OF THE TOTAL NUMBER OF PLANNED PATIENTS MARKS THE END OF FIRST LEG OF THE PIVOTAL STUDY.  Full Article

Carmat Launches Capital Increase For Initial Amount Of 46 Million Euros
Tuesday, 5 Dec 2017 

Dec 5 (Reuters) - Carmat ::LAUNCHES A CAPITAL INCREASE WITHOUT SHAREHOLDERS’ PREFERENTIAL SUBSCRIPTION RIGHTS AND WITH A 4-TRADING DAY PRIORITY SUBSCRIPTION PERIOD ON AN IRREDUCIBLE BASIS TO SHAREHOLDERS FOR AN INITIAL AMOUNT OF €46 MILLION.LAUNCHES A CAPITAL INCREASE WITHOUT SHAREHOLDERS’ PREFERENTIAL SUBSCRIPTION RIGHTS AND WITH A 4-TRADING DAY PRIORITY SUBSCRIPTION PERIOD ON AN IRREDUCIBLE BASIS TO SHAREHOLDERS FOR AN INITIAL AMOUNT OF €46 MILLION.‍LAUNCH OF CAPITAL INCREASE WITHOUT SHAREHOLDERS' PREFERENTIAL SUBSCRIPTION RIGHTS FOR AMOUNT OF EUR 46 MILLION​.‍INITIAL AMOUNT MAY BE INCREASED TO MAX OF EUR 52.9 MILLION IN EVENT OF FULL EXERCISE OF INCREASE OPTION​.‍CAPITAL INCREASE TO SECURE FINAL DEVELOPMENT STAGES BEFORE MARKETING OF TOTAL ARTIFICIAL HEART IN EUROPE​.‍MARKETING OF TOTAL ARTIFICIAL HEART IN EUROPE SCHEDULED FOR 2019​.‍EXISTING SHAREHOLDERS ALREADY COMMITTED TO SUBSCRIBE FOR AMOUNT OF EUR 34.5M​.‍MAX NUMBER OF NEW SHARES THAT MAY BE ISSUED IS 4.0 MILLION.‍BNP PARIBAS AND ODDO BHF SCA ACTING AS GLOBAL COORDINATORS, LEAD MANAGERS AND JOINT-BOOKRUNNERS​.‍PORTZAMPARC IS ACTING AS CO-LEAD MANAGER​.‍MAX SUBSCRIPTION PRICE OF NEW SHARES WILL BE EUR 20 PER SHARE​.  Full Article

Carmat: First Implantation In Czech Republic Within Framework Of Pivotal Study International Expansion
Monday, 27 Nov 2017 

Nov 27 (Reuters) - CARMAT ::FIRST IMPLANTATION IN THE CZECH REPUBLIC WITHIN THE FRAMEWORK OF THE PIVOTAL STUDY INTERNATIONAL EXPANSION.‍COMPLETION EXPECTED BY END OF 2018​.  Full Article

Carmat signs a partnership agreement with AddUp
Monday, 13 Nov 2017 

Nov 13 (Reuters) - CARMAT : :CARMAT SIGNS A PARTNERSHIP AGREEMENT WITH ADDUP, THE MICHELIN AND FIVES JOINT VENTURE SPECIALIZED IN 3D PRINTING.‍AIM OF COLLABORATION IS TO STRENGTHEN INDUSTRIAL DEVELOPMENT OF CARMAT HEART AND CONTRIBUTE TO INCREASE CO'S PRODUCTION CAPACITY IN PREPARATION FOR LARGE SCALE PRODUCTION PHASE​.  Full Article

French group Carmat says gets approval to perform implants in Czech Republic
Monday, 30 Oct 2017 

Oct 30 (Reuters) - Carmat Sa ::* Received the approval to perform, within the framework of the PIVOTAL study protocol approved by the ANSM (French national agency for the safety of medicines and health products), implants of its total artificial heart in patients at the Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic.  Full Article

Carmat FY net loss widens to 23 million euros
Tuesday, 14 Feb 2017 

Carmat SA : Solid cash position of 31.2 million euros ($33.13 million) at December 31, 2016 . FY net loss of 23 million euros versus loss of 17.6 million euros year ago . FY operating income 262,994 euros versus 14,350 euros year ago .Recorded no revenue in 2016.  Full Article

French and Benelux stocks-Factors to watch on August 2

Aug 2 Below are company-related news and stories from French and Benelux media which could have an impact on the region's markets or individual stocks.